Today’s AI Top Pick: PEGA

7/6/2026 · Highly Shorted Analyst Favorites Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Analyst Favorites Deep RotationPEGABUY NOW8.7 / 107/6/2026

PEGA is the cleanest fundamentals-meets-tape setup in this pool. It carries the highest fundamental_score (8) with genuine quality: PE 16.71, fwdPE 10.08, PEG 0.56, ROE 51.74%, profit margin 20.04%, gross margin 74.84%, debt/equity 0.1 — a rare combination of value AND profitability. It's down -48% YTD and -41% on the year with a weekly drawdown of -32.36% and only 10.76% position in the 21-bar weekly range, meaning we are buying deep into a correction, not chasing a top. Analyst recom is 1.27 with 88.4% target upside. The tape confirms: bullish_prob 1.0, near_term_bullish 1.0. The daily forecast is the standout — fc_short +55.87%, fc_mid +22.15%, fc_long +38.63% — and weekly fc_mid +41.34% agrees. 4h shows fc_mid +49.33% / fc_long +68.75%. Yes, the 1h/4h position sits at 97-100% of range, so a small intraday pullback is possible, but the daily bar is only at 47.8% of range with a -9.9% drawdown, so we're not extended on the timeframe that matters. Multi-timeframe agreement is strong on the horizons where money is actually made. News is a tailwind, not a landmine. Yahoo (Jul 5): 'PEGA May Be Cheap Given Its Earnings Power.' StockStory (Jul 2): 'PEGA Shares Are Soaring.' The narrative (Adobe vs Pegasystems AI software comparison) frames PEGA as an AI beneficiary trading at ~10x forward earnings. There are no dilution, guidance-cut, legal, or short-seller headlines to underwrite against. Why today vs waiting: the daily setup just cleared its recent low and the model expects a +56% short-horizon move; waiting risks missing the base breakout while the weekly drawdown gives you a wide, well-defined risk envelope. TMDX and ENOV are close alternatives but have inferior fundamentals (TMDX debt/equity 1.75, ENOV negative profit margin -49.84%). PEGA is the highest-quality name in the deepest drawdown with the tape turning — that's the trade.

Entry zone

$31.00-32.20 (start today at market near $31.90, add on any dip toward $30.50)

Stop loss

$27.80 (below the recent daily swing and ~13% risk; a close below invalidates the base)

First target

$38.50 (fills the daily fc_short zone and prior supply)

Longer target

$46-50 (aligns with weekly fc_mid +41% and analyst target upside of 88.4%)

Risks

Short float 15.33% + 1h/4h position 97-100% of range mean an intraday fade toward $30 is plausible before the daily move fires
Sales YoY only +3.5% — this is a value/re-rating thesis, not a growth story; any enterprise IT spending softness hits hard
YTD -48.02% and 1-year -41.05% show sustained institutional selling; catch-a-falling-knife risk if the weekly downtrend resumes
Weekly fc_short is -3.97%, hinting at one more shakeout candle before the mid-term rally the model projects
Analyst recom 1.27 leaves little room for upgrades; a single downgrade could pressure the tape

Honorable mentions

TMDXBullish_prob 1, deeply oversold (weekly pos 7.92%, dd -52%), daily fc_short +65.25% and 4h fc_long +101.76%. Recent 'Analyst Sees 77% Upside' catalyst. Fund score 6.75 with 27% profit margin and 45% ROE. Slight demerit vs PEGA on debt/equity 1.75 and higher fwdPE 20.3.

ENOVRare full multi-timeframe alignment (1h +13.4%, 4h +15.84%, 1d +34.34%, 1wk +102.06% forecasts), bullish_prob 1, near_term 1, fwdPE 5.52, PEG 0.51, recom 1.27. Held back by negative profit margin (-49.84%) and 1h/4h at 95-100% of range.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PEGA	BUY NOW	8.7	Best fundamentals in the pool (PE 16.7, PEG 0.56, ROE 51.7%) with weekly at 10.8% of range and daily fc_short +55.87% — quality on sale with the tape turning.
2	TMDX	BUY NOW	8.1	Deep-value biotech setup: weekly dd -52%, 4h fc_long +101%, positive analyst catalyst calling 77% upside.
3	ENOV	BUY NOW	7.6	Full 1h/4h/1d/1wk forecast alignment with fwdPE 5.52 and PEG 0.51, though 1h/4h at top of range invites a small pullback.
4	LRN	BUY PULLBACK	6.9	Solid fundamentals (PE 13.95, ROE 20%, +39% YTD) but 4h fc_mid -16.55% and 1wk fc_mid -17.77% suggest better entry lower.
5	PSIX	BUY PULLBACK	6.4	Great value (PE 8.37, ROE 75.7%) and strong daily/4h forecasts, but weekly fc_long -63.61% is a red flag that needs to invalidate first.
6	CRMD	BUY PULLBACK	6.0	Cheap (PE 4.17), high margin, positive news on DefenCath growth, but forecasts turn negative on 1wk (-28.48%).
7	LRMR	BUY PULLBACK	5.9	HC Wainwright buy with $10 PT, weekly fc_long +105%, but biotech risk and no revenue.
8	WING	WAIT	5.8	Strong forecasts and near_term_bullish 0.8, but PE 44 and fwdPE 32 leave little valuation cushion.
9	CELH	BUY PULLBACK	5.7	Growth intact (sales +123% YoY) and momentum improving, but PE 79 and 1h/4h at 100% of range mean wait for a dip.
10	QXO	BUY PULLBACK	5.6	TopBuild acquisition catalyst positive; weekly pos 0.64% shows deep base, but near_term_bullish is 0.
11	VSTM	BUY PULLBACK	5.5	KRAS trial results catalyst, weekly fc_long +111%, but negative margins and high short float.
12	EYE	BUY PULLBACK	5.3	Insider buying and upgrade catalyst, 1wk fc_long +76%, but 1h/4h near range highs.
13	FIP	BUY PULLBACK	5.2	Jones Trading Buy initiation at $8.75, weekly pos 0%, but debt/equity 3.96 is a landmine.
14	PDYN	WAIT	5.0	Defense AI catalysts good, but weekly pos 47% with recent -26% drop shows unstable base.
15	MUX	WAIT	4.9	Fundamentals decent (PEG 0.07, +72% 1-yr) but 1wk fc_long -57.47% and bullish_prob 0 contradict the setup.
16	AISP	WAIT	4.8	Weekly fc_mid +288% eye-catching but SeekingAlpha calls out dilution risk and small backlog.
17	CWH	AVOID	4.7	Two SeekingAlpha 'Sell/Downgrade' pieces and target cuts overwhelm the strong daily forecasts.
18	PROP	WAIT	4.6	Explosive fc_long +341% but debt/equity 1222 and CEO/CFO change create binary risk.
19	ASST	WAIT	4.4	Bitcoin-treasury narrative, but PS 187 and profit margin -12,110% make this a lottery ticket.
20	PGY	WAIT	4.3	Great fundamentals (PEG 0.21, PE 17.7, recom 1) but bullish_prob 0 and 1wk fc_short -28% contradict thesis.
21	DLO	WAIT	4.0	UBS upgrade and Russell 2000 inclusion positive, but bullish_prob 0, all near forecasts negative, at 100% of daily range.
22	CTXR	AVOID	3.9	$15M market cap penny with operating margin -1041%; forecast noise, not signal.
23	CXT	AVOID	3.8	RSI 77 overbought at 100% of range with all forecasts turning negative on 1wk (-13.62%).
24	BKV	WAIT	3.7	Decent fundamentals but bullish_prob 0, all daily forecasts negative, and dilution SeekingAlpha piece.
25	GRCE	WAIT	3.6	Weekly fc_long +56% but $38M micro-cap with no revenue and recent -34% weekly.
26	VYX	AVOID	3.4	1h fc_long -21.76% and 4h fc_long -5.88%, bullish_prob only 0.4 at 100% of range on daily.
27	CNXC	AVOID	3.3	Negative margins, YTD -43%, and modest 38.8% target upside — no catalyst to reverse trend.
28	SPRY	AVOID	3.0	Just kicked out of Russell 2000 Defensive indices, -11.5% drop with -200% profit margin.
29	SERV	AVOID	2.8	Operating margin -2843%, PS 93.89, board resignation, and weekly pos suggests broken chart.
30	DVLT	AVOID	2.5	Weekly forecasts print -100% across short/mid/long — model flagging existential risk.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord